Intervention

Trimetazidine

ClinicalTrials.gov intervention label

Clinical trials6

Recruiting0

Common conditions7

Lead sponsors shown6

Clinical trials

6 shown

Trimetazidine Efficacy in Attenuating Paclitaxel-Induced Peripheral NeuropathyNCT06459193 · 2024-06-23

The Effects of TMZ on Diabetic NephropathyNCT05147194 · 2022-01-01

Effect of Trimetazidine on Radiotherapy-induced Heart Damage.NCT04939857 · 2021-06-25

The Role of Trimetazidine on Right Ventricle Function in Pulmonary Arterial HypertensionNCT03273387 · 2017-09-10

Trimetazidine in Pulmonary Artery HypertensionNCT02102672 · 2014-03-01

Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart DiseaseNCT00282360 · 1999-02-01

Common conditions

Cardiotoxicity1 Coronary Artery Disease1 Diabetic Nephropathies1 Peripheral Neuropathy Due to Chemotherapy1 Precapillary Pulmonary Hypertension1 Pulmonary Artery Hypertension1 Type II Diabetes Mellitus1

Leading sponsors

IRCCS San Raffaele1 Minia University1 Peking University Third Hospital1 Pontificia Universidad Catolica de Chile1 Tongji Hospital1 Universitas Indonesia1

Trial status mix

COMPLETED3

UNKNOWN3

Phase mix

PHASE25

PHASE32

PHASE11

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.